<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1980">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04381013</url>
  </required_header>
  <id_info>
    <org_study_id>57573</org_study_id>
    <nct_id>NCT04381013</nct_id>
  </id_info>
  <brief_title>Emergency Ventilator Splitting Between Two or More Patients (COVID-19)</brief_title>
  <official_title>Emergency Ventilator Splitting Between Two or More Patients Using a Single Ventilator to Address Critical Ventilator Shortages During a Pandemic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to develop a safe, easily scalable, and simple method to split a
      single ventilator for use amongst two or more patients, thus serving as a capacity bridge to
      save patient lives until manufacturers can produce enough ventilators.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2020</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Completion of 1-minute test</measure>
    <time_frame>Up to 1 minute</time_frame>
    <description>This outcome will measure whether the device will function for respiratory support for 1 minute (yes or no; phase 1 only)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Completion of 24-hour test</measure>
    <time_frame>Up to 1 minute</time_frame>
    <description>This outcome will measure whether the device will function for respiratory support for 24 hours (yes or no; phase 2 only)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Completion of 24-hour test</measure>
    <time_frame>Up to 1 hour</time_frame>
    <description>This outcome will measure whether the device will function for respiratory support for 1 hour (yes or no; phase 3 only)</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">4</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Phase 1: Routine surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>As part of routine cardio-thoracic surgery, endotracheal tubes split from ventilator delivering oxygen independently to each lung for up to 1 minute.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase 2: ECHO treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>During care with Extracorporeal Membrane Oxygenation (ECMO) for non-SARS-CoV-2, endotracheal tubes split from ventilator delivering oxygen independently to each lung for up to 24 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase 3: COVID-19 treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Endotracheal tubes split from ventilator delivering oxygen independently to two patients with COVID-19 disease for up to 1 hour.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Emergency Ventilator Splitter</intervention_name>
    <description>Device to enable oxygen delivery to two patients independently from a single ventilator.</description>
    <arm_group_label>Phase 1: Routine surgery</arm_group_label>
    <arm_group_label>Phase 2: ECHO treatment</arm_group_label>
    <arm_group_label>Phase 3: COVID-19 treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Phase I

               -  Undergoing routine thoracic surgery which will include the use of a dual lumen
                  endotracheal tube at Stanford.

          -  Phase II

               -  Able to give consent

               -  On venovenous extracorporeal membrane oxygenation for reason other than COVID-19

          -  Phase III

               -  Able to give consent

               -  Infected with COVID-19 and will likely require mechanical ventilation.

        Exclusion Criteria:

          -  Phase I

               -  Significant cardiac comorbidities

               -  Liver disease

          -  Phase II

               -  Significant cardiac comorbidities

               -  Pre or Post-transplant patient

               -  Infection with COVID-19

          -  Phase III

               -  Co-infection with disease aside from COVID-19

               -  Severely ill requiring high ventilator requirements and not stable for ventilator
                  splitting
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph Woo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>May 7, 2020</study_first_submitted>
  <study_first_submitted_qc>May 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2020</study_first_posted>
  <last_update_submitted>October 5, 2020</last_update_submitted>
  <last_update_submitted_qc>October 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No plan to share data.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

